| Q58856101 | Blood biomarkers as predictors of long-term mortality in COPD |
| Q35387845 | Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA. |
| Q46750635 | Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers |
| Q34304837 | Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction |
| Q28395449 | MMP-2 and TIMP-1 predict healing of WTC-lung injury in New York City firefighters |
| Q34119539 | Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease |
| Q55269439 | Surfactant Protein D in Respiratory and Non-Respiratory Diseases. |
| Q34636461 | Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease |
| Q34676410 | Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values |
| Q89736483 | TIMP-1 and MMP-9 expressions in COPD patients complicated with spontaneous pneumothorax and their correlations with treatment outcomes |